ArticleBJR case reports2026
Hypofractionated palliative radiotherapy for advanced ethmoid sinus squamous cell carcinoma: a case report.
Article in BJR case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ethmoid sinus cancer is a rare malignancy, that is, often diagnosed at an advanced stage, making surgical intervention challenging. Herein, we report a case of advanced ethmoid sinus squamous cell carcinoma in a female patient in her 90s. The patient presented with right-sided proptosis, ptosis, diplopia, and nasal obstruction. She was considered unfit for radical surgery or chemoradiotherapy because of her age and other comorbidities. She underwent hypofractionated palliative radiotherapy (35 Gy in 5 fractions) targeting the clinical tumor volume only. Clinically meaningful symptom relief and substantial tumor shrinkage were observed post-treatment, with minimal acute toxicities, although conclusions regarding treatment efficacy should be interpreted cautiously given the single-patient nature of this report. This case illustrates the potential of hypofractionated radiotherapy as a palliative option for patients deemed unsuitable for radical treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.